Product Information
NYSTATIN 500,000 UNIT ORAL TAB is a generic product labeled by Heritage Pharmaceuticals Inc., priced at $0.3970 per EA under NDC 23155005101. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Dec 22, 1983. Its Orange Book therapeutic-equivalence code is AA.
Strength
500000 [USP'U]/1
Manufacturer
Heritage Pharmaceuticals Inc.NDC
23155005101
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NYSTATINApproval Type
Generic (ANDA)
FDA Application
ANDA062474FDA Approved
12/22/1983
TE Code
AA
On Market Since
10/31/2011
Pharmacological Classes
Price Statistics
The NADAC for NYSTATIN 500,000 UNIT ORAL TAB has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 12.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3970 per EA |
|---|---|
| All-time high | $0.7272 (Jan 11, 2017) |
| All-time low | $0.2644 (Apr 17, 2024) |
| 52-week high | $0.4129 |
| 52-week low | $0.3521 |
| Median price | $0.4351 |
| Average price | $0.4483 |
| Largest weekly change | +37.0% (Jun 21, 2017) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the nystatin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Heritage Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
nystatin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Polyene Antifungal class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NYSTATIN 500,000 UNIT ORAL TAB?
The current National Average Drug Acquisition Cost (NADAC) for NYSTATIN 500,000 UNIT ORAL TAB, manufactured by Heritage Pharmaceuticals Inc., is $0.3970 per EA (NDC 23155005101), effective Sep 30, 2026.
How has the price of NYSTATIN 500,000 UNIT ORAL TAB changed over time?
Over the history we have for it, the NADAC for NYSTATIN 500,000 UNIT ORAL TAB has declined 12.4%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NYSTATIN 500,000 UNIT ORAL TAB?
Since Nov 28, 2013, the NADAC for NYSTATIN 500,000 UNIT ORAL TAB has ranged from a low of $0.2644 (Apr 17, 2024) to a high of $0.7272 (Jan 11, 2017), with a median of $0.4351 per EA.
Are there cheaper alternatives to NYSTATIN 500,000 UNIT ORAL TAB?
No other NADAC-published product currently shares the active ingredient and strength of NYSTATIN 500,000 UNIT ORAL TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures NYSTATIN 500,000 UNIT ORAL TAB?
NYSTATIN 500,000 UNIT ORAL TAB (NDC 23155005101) is labeled by Heritage Pharmaceuticals Inc., and CMS classifies it as a generic product.